E3 PreliminaryPreliminaryPEM unclearReview-NarrativePeer-reviewedMachine draft
[Childhood chronic fatigue syndrome].
Miike, Teruhisa · Nihon rinsho. Japanese journal of clinical medicine · 2007
Quick Summary
This review discusses chronic fatigue syndrome (CFS) in children and teenagers, a serious condition affecting 3-5% of young people. Children with CFS experience extreme tiredness, sleep problems, trouble learning and remembering, and immune system issues. While routine blood tests often look normal, special testing can reveal abnormalities in how their bodies handle energy, regulate temperature, and control hormones.
Why It Matters
Understanding CFS in children is critical because early-onset disease may have different pathophysiology and long-term outcomes than adult-onset CFS. Establishing pediatric-specific diagnostic criteria and identifying measurable biomarkers can improve recognition, validate the biological basis of the condition, and guide targeted interventions before disease becomes entrenched.
Observed Findings
- Up to 3-5% of children and adolescents experience prolonged fatigue and confusion lasting more than 30 days
- Four major symptoms characterize CCFS: sleep disorders, easy fatigability, learning and memory disturbance, and immunological dysfunction
- Abnormalities detected in serum pyruvic acid levels, oral glucose tolerance test patterns, deep body temperature rhythms, hormonal secretion timing, and cerebral blood flow despite normal routine laboratory tests
- A formal CCFS case definition was developed in 2004 by a Japanese Ministry of Health, Labor and Welfare-supported research group
Inferred Conclusions
- CCFS is a complex, debilitating condition with measurable biochemical and physiological abnormalities that differ from typical laboratory findings
- Circadian rhythm dysregulation and energy metabolism impairment are central pathophysiological features in pediatric CFS
- Therapeutic approaches should target restoration of disrupted circadian rhythms and correction of energy substrate supply
Remaining Questions
- What is the long-term natural history and prognosis of CCFS compared to adult-onset CFS?
- Which specific biomarkers (pyruvate, hormonal patterns, cerebral blood flow indices) are most useful for diagnosis and monitoring treatment response?
What This Study Does Not Prove
This review does not establish causation for any observed abnormalities, nor does it prove that circadian rhythm correction and energy supplementation are effective treatments—it only suggests they are reasonable therapeutic targets. The study provides no original experimental data and does not determine whether the 3-5% prevalence figure applies across all populations or countries. No treatment outcomes are quantified.
Tags
Symptom:Cognitive DysfunctionUnrefreshing SleepFatigueTemperature Dysregulation
Biomarker:MetabolomicsBlood Biomarker
Phenotype:Pediatric
Method Flag:Weak Case DefinitionExploratory Only
Metadata
- PMID
- 17561704
- Review status
- Machine draft
- Evidence level
- Early hypothesis, preprint, editorial, or weak support
- Last updated
- 10 April 2026
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Spotted an error in this entry? Report it →